Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
PASO-DOBLE-studie: hiv-behandeling optimaliseren zonder in te leveren op effectiviteit
apr 2026